Chief Medical Officer
Related ArticlesView All
5 Ways to Improve Medication Adherence for Pediatric ADHD Clinical Trial Participants
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental behavioral disorder in childhood and adolescence. The worldwide pooled prevalence in this population is estimated to be 6-8%, with estimates varying depending on measurement methodology.
Neuropathic Pain Trials Combine Drug Adherence, E-Diaries for Personalized Interventions
The percentage of people in pain around the world rose from 26.3% in 2009 to 32.1% in 2021, an increase of approximately 500 million people. Persistent pain in the U.S. is estimated to affect over 100 million adults at any given time, and carries direct and indirect costs of over $600 billion annually.
Psoriasis Clinical Trials Aim to Improve Disease Management, Drug Adherence
Psoriasis is an immune-mediated inflammatory disease, with a chronic relapsing-remitting course, which affects 2–3% of the worldwide population. This blog provides a brief overview of medication adherence in psoriasis, a snapshot of the psoriasis clinical trial landscape, and a look at technology used to improve dosing performance in psoriasis clinical research.